William S. Caldwell Insider Profile
4 Followers
William S. Caldwell, SVP - Drug Discovery and Dev. at Gyre Therapeutics, holds 9.73K shares in Gyre Therapeutics (Ticker: GYRE).
William S. Caldwell's Trading History
| GYREGyre Therapeutics | Sep 29, 2011 | SVP - Drug Discovery and Dev. | Uninformative Sell | ― | $41.96K | |
GYRE Insider Shares: 9.73K (0.09%) | ||||||
You May Also Like
William S. Caldwell insider profile FAQ
What is the percentage of profitable transactions made by William S. Caldwell?
The percentage of profitable transactions made by William S. Caldwell is 33%.
What is the average return per transaction made by William S. Caldwell?
The average return per transaction made by William S. Caldwell is -0.60%.
What stocks does William S. Caldwell hold?
William S. Caldwell holds: GYRE stocks.
What was William S. Caldwell's most profitable transaction?
William S. Caldwell’s most profitable transaction was an Informative Sell of GYRE stock on December 14, 2010. The return on the trade was 67.40%.
What is William S. Caldwell's role in Gyre Therapeutics?
William S. Caldwell's role in Gyre Therapeutics is SVP - Drug Discovery and Dev..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
